Donald G. Payan
#166,373
Most Influential Person Now
Donald G. Payan's AcademicInfluence.com Rankings
Donald G. Payanphilosophy Degrees
Philosophy
#9812
World Rank
#13426
Historical Rank
Logic
#6769
World Rank
#8317
Historical Rank

Donald G. Payanbiology Degrees
Biology
#13504
World Rank
#17052
Historical Rank
Immunology
#934
World Rank
#958
Historical Rank
Molecular Biology
#2290
World Rank
#2324
Historical Rank
Biochemistry
#2368
World Rank
#2518
Historical Rank

Download Badge
Philosophy Biology
Donald G. Payan's Degrees
- PhD Biochemistry University of California, Berkeley
- Doctorate Medicine Stanford University
Why Is Donald G. Payan Influential?
(Suggest an Edit or Addition)Donald G. Payan's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation (2006) (475)
- Specific stimulation of human T lymphocytes by substance P. (1983) (468)
- Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. (1996) (460)
- R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer. (2010) (436)
- Substance P selectively activates TNF-alpha gene expression in murine mast cells. (1993) (348)
- Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. (1997) (325)
- Structure and expression of a rat agrin (1991) (309)
- Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2. (1997) (308)
- Neutrophil rolling altered by inhibition of L-selectin shedding in vitro (1996) (304)
- Neuropeptides and inflammation: the role of substance P. (1989) (290)
- Modulation of immunity and hypersensitivity by sensory neuropeptides. (1984) (286)
- Mechanisms of Desensitization and Resensitization of Proteinase-activated Receptor-2* (1996) (269)
- Substance P recognition by a subset of human T lymphocytes. (1984) (256)
- Discovering patterns to extract protein-protein interactions from full texts (2004) (238)
- Delineation of the endocytic pathway of substance P and its seven-transmembrane domain NK1 receptor. (1995) (231)
- Characterization of Antisera Specific to NK1, NK2, and NK3 Neurokinin Receptors and their Utilization to Localize Receptors in the Rat Gastrointestinal Tract (1996) (213)
- Detection of programmed cell death using fluorescence energy transfer. (1998) (212)
- Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor. (2007) (207)
- A new algorithm for the evaluation of shotgun peptide sequencing in proteomics: support vector machine classification of peptide MS/MS spectra and SEQUEST scores. (2003) (200)
- Multiple roles for the receptor tyrosine kinase axl in tumor formation. (2005) (195)
- Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts. (1984) (181)
- Stereospecific receptors for substance P on cultured human IM-9 lymphoblasts. (1984) (172)
- An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus. (2008) (170)
- Distribution of substance P receptors on murine spleen and Peyer's patch T and B cells. (1987) (169)
- TNIK, a Novel Member of the Germinal Center Kinase Family That Activates the c-Jun N-terminal Kinase Pathway and Regulates the Cytoskeleton* (1999) (168)
- Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth. (2005) (166)
- The control of microvascular permeability and blood pressure by neutral endopeptidase (1997) (159)
- Targeting Syk as a treatment for allergic and autoimmune disorders (2004) (154)
- Agonist-induced internalization of the substance P (NK1) receptor expressed in epithelial cells. (1994) (148)
- Modulation of lymphocyte function by sensory neuropeptides. (1985) (141)
- Neuropeptide regulation of the expression of immediate hypersensitivity. (1985) (138)
- Quantitative measurement of mast cell degranulation using a novel flow cytometric annexin-V binding assay. (1999) (134)
- Activation of the PKB/AKT pathway by ICAM-2. (2002) (133)
- Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B4. (1984) (125)
- Neuropeptide Modulation of Leukocyte Function a (1987) (123)
- Immunomodulation by Tachykinin Neuropeptides a (1990) (120)
- Identification of RIP3, a RIP-like kinase that activates apoptosis and NFκB (1999) (116)
- p15PAF, a novel PCNA associated factor with increased expression in tumor tissues (2001) (107)
- Receptor-mediated mitogenic effects of substance P on cultured smooth muscle cells. (1985) (106)
- Specific suppression of human T lymphocyte function by leukotriene B4. (1983) (105)
- Binding characteristics and affinity labeling of protein constituents of the human IM-9 lymphoblast receptor for substance P. (1986) (99)
- Human bleomycin hydrolase: molecular cloning, sequencing, functional expression, and enzymatic characterization. (1996) (99)
- Effect of eicosapentaenoic acid in asthma (1988) (94)
- The antagonistic effect of an inhalation anesthetic and high pressure on the phase diagram of mixed dipalmitoyl-dimyristoylphosphatidylcholine bilayers. (1975) (93)
- Substance P and bradykinin stimulate plasma extravasation in the mouse gastrointestinal tract and pancreas. (1997) (93)
- Stimulation of rat B‐lymphocyte proliferation by corticotropin‐releasing factor (1989) (90)
- Direct Observation of Endocytosis of Gastrin Releasing Peptide and Its Receptor (*) (1995) (89)
- Retrovirally Delivered Random Cyclic Peptide Libraries Yield Inhibitors of Interleukin-4 Signaling in Human B Cells* (2002) (89)
- Endocytosis and recycling of neurokinin 1 receptors in enteric neurons (1996) (88)
- Riboproteomics of the hepatitis C virus internal ribosomal entry site. (2004) (84)
- Dominant effector genetics in mammalian cells (2001) (84)
- Identification of Potential Tyrosine-containing Endocytic Motifs in the Carboxyl-tail and Seventh Transmembrane Domain of the Neurokinin 1 Receptor* (1997) (83)
- Identification of the Syk kinase inhibitor R112 by a human mast cell screen. (2006) (82)
- Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid (1986) (82)
- Multiple intracellular signaling pathways of the neuropeptide substance P receptor (1992) (80)
- The Poxvirus p28 Virulence Factor Is an E3 Ubiquitin Ligase* (2004) (78)
- Rab37 is a novel mast cell specific GTPase localized to secretory granules (2000) (76)
- Multiple signaling pathways of histamine H2 receptors. Identification of an H2 receptor-dependent Ca2+ mobilization pathway in human HL-60 promyelocytic leukemia cells. (1989) (74)
- Systematic identification of regulatory proteins critical for T-cell activation (2003) (72)
- Pressure-induced elevation of phase transition temperature in dipalmitoylphosphatidylcholine bilayers. An electron spin resonance measurement of the enthalpy of phase transition. (1974) (72)
- Distribution of somatostatin receptors on murine spleen and Peyer's patch T and B lymphocytes (1987) (71)
- Discovery and development of spleen tyrosine kinase (SYK) inhibitors. (2012) (70)
- Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB. (1999) (69)
- Inhibition by somatostatin of the release of mediators from human basophils and rat leukemic basophils. (1984) (67)
- JAK3 Inhibition Significantly Attenuates Psoriasiform Skin Inflammation in CD18 Mutant PL/J Mice (2009) (67)
- Drug discovery in the ubiquitin regulatory pathway. (2003) (66)
- Cell cycle regulatory E3 ubiquitin ligases as anticancer targets. (2002) (66)
- Molecular Cloning, Chromosomal Localization, and Expression of Murine Dipeptidyl Peptidase I* (1997) (65)
- Functional Cloning of Src-like Adapter Protein-2 (SLAP-2), a Novel Inhibitor of Antigen Receptor Signaling (2001) (65)
- Downregulation of neutral endopeptidase (EC 3.4.24.11) in the inflamed rat intestine. (1993) (63)
- Preclinical characterization of Aurora kinase inhibitor R763/AS703569 identified through an image-based phenotypic screen (2009) (62)
- Interactions between neutral endopeptidase (EC 3.4.24.11) and the substance P (NK1) receptor expressed in mammalian cells. (1994) (62)
- Substrate Modification with Lysine 63-linked Ubiquitin Chains through the UBC13-UEV1A Ubiquitin-conjugating Enzyme* (2007) (59)
- Defective polymorphonuclear leukocyte chemotaxis in homosexual men with persistent lymph node syndrome. (1984) (56)
- The mitogenic effects of vasoactive neuropeptides on cultured smooth muscle cell lines. (1987) (55)
- In Vitro Studies of Immunoregulation by Substance P and Somatostatin (1987) (54)
- A Novel E3 Ubiquitin Ligase TRAC-1 Positively Regulates T Cell Activation (2005) (54)
- Retroviral delivery of peptide modulators of cellular functions. (2000) (54)
- Identification and Functional Characterization of a Novel Human Misshapen/Nck Interacting Kinase-related Kinase, hMINKβ* (2004) (53)
- AMPK Activation through Mitochondrial Regulation Results in Increased Substrate Oxidation and Improved Metabolic Parameters in Models of Diabetes (2013) (52)
- Endogenous somatostatin-like peptides of rat basophilic leukemia cells. (1985) (50)
- Intracellular protein scaffold-mediated display of random peptide libraries for phenotypic screens in mammalian cells. (2001) (49)
- Dual Roles of Substance P: Modulator of Immune and Neuroendocrine Functions a (1987) (49)
- The murine IgA-secreting plasmacytoma MOPC-315 expresses somatostatin receptors. (1988) (45)
- Infection of a brain abscess of Mycoplasma hominis (1981) (45)
- R 428 , a Selective Small Molecule Inhibitor of Axl Kinase , Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer (2010) (44)
- Isoforms of agrin are widely expressed in the developing rat and may function as protease inhibitors. (1993) (43)
- Multiple signaling pathways of histamine H2 receptors. (1991) (42)
- Substance P receptor-dependent responses of leukocytes in pulmonary inflammation. (1987) (41)
- Inhibition of Janus kinase signaling during controlled mechanical ventilation prevents ventilation-induced diaphragm dysfunction (2014) (40)
- Multiple functional categories of proteins identified in an in vitro cellular ubiquitin affinity extract using shotgun peptide sequencing. (2003) (40)
- Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice. (2014) (38)
- A Novel Role for p21-Activated Protein Kinase 2 in T Cell Activation (2004) (38)
- Identification of a nuclear-specific cyclophilin which interacts with the proteinase inhibitor eglin c. (1996) (37)
- Binding of viridans group streptococci to human platelets: a quantitative analysis (1990) (36)
- The JAK-STAT Pathway Is Critical in Ventilator-Induced Diaphragm Dysfunction (2014) (36)
- Generation of a unique fibroblast-activating factor by human monocytes. (1984) (35)
- A basophil-activating factor from human T lymphocytes. (1984) (34)
- Discovering Patterns to Extract Protein-Protein Interactions from Full Biomedical Texts (2004) (34)
- Measles virus-substance P receptor interactions. Possible novel mechanism of viral fusion. (1990) (34)
- PathwayFinder: Paving the Way Towards Automatic Pathway Extraction (2004) (34)
- The use of retroviruses as pharmaceutical tools for target discovery and validation in the field of functional genomics. (2001) (34)
- Characterization of receptors using cyanine 3-labeled neuropeptides (1995) (34)
- Stable, stoichiometric delivery of diverse protein functions. (2004) (33)
- Identification and functional characterization of a novel human misshapen/Nck interacting kinase-related kinase, hMINK beta. (2004) (33)
- High-throughput screening for inhibitors of the e3 ubiquitin ligase APC. (2005) (32)
- R723, a selective JAK2 inhibitor, effectively treats JAK2V617F-induced murine myeloproliferative neoplasm. (2011) (31)
- Amyloid beta protein substituent peptides do not interact with the substance P receptor expressed in cultured cells. (1991) (31)
- Functional diversity of histamine and histamine receptors. (1992) (30)
- Modulation of human lymphocyte function by C3a and C3a(70-77) (1982) (29)
- A novel artificial loop scaffold for the noncovalent constraint of peptides. (2000) (28)
- A Class of Small Molecules that Inhibit TNFα-Induced Survival and Death Pathways via Prevention of Interactions between TNFαRI, TRADD, and RIP1 (2007) (28)
- Substance P and immunoregulation. (1987) (28)
- Characterization and Use of Green Fluorescent Proteins from Renilla mulleri and Ptilosarcus guernyi for the Human Cell Display of Functional Peptides (2001) (26)
- Characterization of functional histamine H1 receptors on a cultured smooth muscle cell line (1988) (26)
- Potentiation of mitogen-induced human T-lymphocyte activation by retinoic acid. (1985) (26)
- Abnormal responses to aspirin of leukocyte oxygenation of arachidonic acid in adults with aspirin intolerance. (1986) (26)
- 9 – Biochemical and Cellular Characteristics of the Regulation of Human Leukocyte Function by Lipoxygenase Products of Arachidonic Acid (1984) (25)
- The current status and the future of JAK2 inhibitors for the treatment of myeloproliferative diseases (2010) (24)
- Substance P: a modulator of neuroendocrine-immune function. (1989) (24)
- Phorbol ester-mediated desensitization of histamine H1 receptors on a cultured smooth muscle cell line. (1988) (24)
- Optimization of regulated LTR-mediated expression. (2000) (24)
- Stimulation of transcriptional regulatory activity by substance P. (1994) (23)
- Immunologie Properties of Substance P (1991) (23)
- The effect of pressure on the phase diagram of mixed dipalmitoyl-dimyristoylphosphatidylcholine bilayers. (1974) (22)
- Purification of the 33,000‐dalton ligand binding‐protein constituent of the lymphoblast substance P receptor (1987) (21)
- R-253 Disrupts Microtubule Networks in Multiple Tumor Cell Lines (2006) (21)
- Developing structure-activity relationships from an HTS hit for inhibition of the Cks1-Skp2 protein-protein interaction. (2015) (21)
- Distribution and abundance of neutral endopeptidase (EC 3.4.24.11) in the alimentary tract of the rat. (1993) (20)
- Transient expression of the angiotensin II receptor: a rapid and functional analysis of a calcium-mobilizing seven-transmembrane domain receptor in COS-7 cells. (1989) (20)
- Role of peptidergic neurons in ocular herpes simplex infection in mice (1989) (20)
- Immunoaffinity purification of membrane protein constituents of the IM-9 lymphoblast receptor for substance P. (1987) (20)
- Neuropeptide regulation of immediate and delayed hypersensitivity. (1988) (19)
- Receptor glycosylation regulates the affinity of histamine H1 receptors during smooth muscle cell differentiation. (1989) (18)
- Processing of the human IM-9 lymphoblast substance P receptor. Biosynthetic and degradation studies using a monoclonal anti-receptor antibody. (1988) (18)
- Use of MEDUSA-based data analysis and capillary HPLC-ion-trap mass spectrometry to examine complex immunoaffinity extracts of RBAp48. (2002) (18)
- A class of small molecules that inhibit TNFalpha-induced survival and death pathways via prevention of interactions between TNFalphaRI, TRADD, and RIP1. (2007) (17)
- Design and application of a versatile triple-laser cell and chromosome sorter. (1987) (16)
- Development of receptors for leukotriene B4 on HL-60 cells induced to differentiate by 1 alpha,25-dihydroxyvitamin D3. (1986) (15)
- Interleukin‐3 modulation of mouse bone marrow derived mast cell receptors for somatostatin (1987) (15)
- Measles virus-substance P receptor interactions: Jurkat lymphocytes transfected with substance P receptor cDNA enhance measles virus fusion and replication (1992) (15)
- Global metabolite profiling of mice with high-fat diet-induced obesity chronically treated with AMPK activators R118 or metformin reveals tissue-selective alterations in metabolic pathways (2014) (14)
- Distinctive patterns of release of neuroendocrine peptides after nasal challenge of allergic subjects with ryegrass antigen (1988) (14)
- Characterization of a monoclonal antibody against the lymphoblast substance P receptor. (1987) (14)
- Immunopathogenetic roles of leukotrienes in human diseases (1984) (13)
- Cellular localization and antiproliferative effect of peptides discovered from a functional screen of a retrovirally delivered random peptide library. (2003) (13)
- Recognition of leukotriene B4 by a unique subset of human T-lymphocytes. (1984) (13)
- A homogeneous FRET assay system for multiubiquitin chain assembly and disassembly. (2005) (13)
- Utility of peptide-protein affinity complexes in proteomics: identification of interaction partners of a tumor suppressor peptide. (2008) (12)
- Interactions between the nervous and the immune systems (1991) (12)
- Expression of substance P and somatostatin receptors on a T helper cell line. (1987) (12)
- Tachykinin receptor cross-talk Immunological cross-reactivity between the external domains of the substance K and substance P receptors (1991) (11)
- Molecular and cellular analysis of histamine H1 receptors on cultured smooth muscle cells (1989) (11)
- Structural diversity of the fibroblast-activating factors generated by human blood monocytes and U937 cells. (1985) (11)
- The use of 33P-labeled oligonucleotides for in situ hybridization of vertebrate embryo frozen sections. (1993) (10)
- Developing DYRK inhibitors derived from the meridianins as a means of increasing levels of NFAT in the nucleus. (2017) (9)
- Discovery and Characterization of Substituted Diphenyl Heterocyclic Compounds as Potent and Selective Inhibitors of Hepatitis C Virus Replication (2008) (8)
- Specific high-affinity binding sites for a synthetic gliadin heptapeptide on human peripheral blood lymphocytes. (1987) (8)
- Neuro-endocrine interaction on lymphocytes Testosterone-induced modulation of the lymphocyte substance P receptor (1990) (8)
- Janus kinase inhibition prevents cancer- and myocardial infarction-mediated diaphragm muscle weakness in mice (2016) (8)
- The dependence of human T-lymphocyte migration on the 5-lipoxygenation of endogenous arachidonic acid (1981) (7)
- Novel regulatory mechanisms of IgA synthesis: respective roles of neuropeptides and cells of the anti-suppressor circuit. (1987) (6)
- Design, synthesis of diaminopyrimidine inhibitors targeting IgE- and IgG-mediated activation of Fc receptor signaling. (2015) (6)
- Solubilization and characterization of the pyrilamine-binding protein from cultured smooth muscle cells. (1989) (6)
- Changes in immunoregulatory lymphocyte populations in patients with histoplasmosis (1984) (6)
- Histamine effects on the 5‐HT1c receptor expressed in Xenopus oocytes (1991) (6)
- Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B 4 ( leukocyte / lipoxygenase / hydroxyicosatetraenoic acid / immunosuppression / hypersensitivity ) (6)
- CHAPTER 13 – EFFECTS OF EICOSAPENTAENOIC ACID ON IMMUNE RESPONSES AND INFLAMMATION IN HUMANS1 (1986) (5)
- MECHANISMS REGULATING THE RESPONSIVENESS OF CELLS TO SUBSTANCE P : CELL-SURFACE DEGRADATION OF SUBSTANCE P AND NK-1 RECEPTOR ENDOCYTOSIS (1994) (5)
- Agonistic activities of histamine-albumin conjugates at histamine H2 receptors on human HL-60 promyelocytic leukemia cells. (1991) (5)
- Functional and immunological responses of Jurkat lymphocytes transfected with the substance P receptor (1992) (5)
- In Vitro and in Vivo Inhibition of JAK2 Signaling by Potent and Selective JAK2 Inhibitor (2008) (5)
- Computational and experimental studies on human misshapen/NIK-related kinase MINK-1. (2004) (4)
- Abstract 346: Potential role for R191, potent and selective IRAK4 kinase inhibitor, in treatment of hematologic malignancies (2016) (4)
- Cellular interacting proteins of functional screen-derived antiproliferative and cytotoxic peptides discovered using shotgun peptide sequencing. (2003) (4)
- Discovery and development of an aurora kinase inhibitor clinical candidate using an image-based assay for measuring proliferation, apoptosis, and DNA content. (2009) (4)
- Multidimensional data integration and relationship inference (2002) (4)
- Noninvasive Imaging of In Vivo MuRF1 Expression during Muscle Atrophy (2014) (3)
- Gas phase dimerization of neuropeptide head activator analogs useful for the noncovalent constraint of peptides. (2007) (3)
- Application of cultured human mast cells (CHMC) for the design and structure-activity relationship of IgE-mediated mast cell activation inhibitors. (2015) (3)
- Characterization of the lymphocyte substance P receptor (1986) (2)
- Antibodies to the rat substance P receptor: production and characterization (1992) (2)
- Selective Small Molecule Inhibitor of Axl Kinase , Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer (2010) (2)
- Mediation of pulmonary immunity and hypersensitivity by neuropeptides. (1986) (2)
- Approaches to discovering drugs that regulate E3 ubiquitin ligases. (2008) (2)
- Evaluation and Management of Patients with Collagen Vascular Disease (1994) (2)
- Detection of naturally expressed receptors for gastrin-releasing peptide and tachykinins using cyanine 3-labelled neuropeptides (1996) (2)
- Indomethacin enhances the proliferation of mitogen-stimulated T lymphocytes of homosexual males with persistent generalized lymphadenopathy (1984) (1)
- Erratum to: The current status and the future of JAK2 inhibitors for the treatment of myeloproliferative diseases (2010) (1)
- Discovery of 5-Aryl-2,4-diaminopyrimidine Compounds as Potent and Selective IRAK4 Inhibitors. (2022) (1)
- PathwayFinder : Bridging the Way Towards Automatic Pathway Extraction (2003) (1)
- A Novel Role for p 21-Activated Protein Kinase 2 in T Cell Activation (2004) (1)
- Mutant PL / J Mice Psoriasiform Skin Inflammation in CD 18 JAK 3 Inhibition Significantly Attenuates (2009) (1)
- Nucleophile Labeling of Cysteine and Serine Protease Substrates* (1996) (1)
- Suppression of tumor growth and angiogenesis by novel small molecule inhibitors of the axl receptor tyrosine kinase (2008) (1)
- Discovery and Characterization of Substituted Diphenyl Heterocyclic Compounds as Potent and Selective Inhibitors of Hepatitis C Virus Replication (cid:1) (2008) (0)
- AMPK activation by a novel small molecule of mitochondrial regulation enhances fatty acid oxidation, ketogenesis and branched chain amino acid catabolism in vivo (2013) (0)
- The Apparent Lack of Cell Cycle Dependency for Substance P Binding to Murine Lymphocytes (1992) (0)
- Structure activity relationships leading to the identification of the indirect activator of AMPK, R419. (2022) (0)
- Testing multiple parameters facs to detect alterations in cellular parameters. (1999) (0)
- Compliance in Taking Medications (2005) (0)
- Identification and Functional Characterization of a Novel Human Misshapen/Nck Interacting Kinase-related Kinase, hMINKÎ2* (2004) (0)
- Abstract B060: Small molecule inhibitors of the anti-inflammatory TAM receptor MerTK (2016) (0)
- Proteomics Approach for Identifying Interacting Partners of a C-Terminal Functional Peptide Derived from the Tumor Suppressor, p21 cip/waf1 (2001) (0)
- Selective inhibitors of JAK2 kinase as potential therapeutic agents (2007) (0)
- 2,4-pyrimidinediamine compounds and of their applications. (2003) (0)
- A Novel Role for p21-Activated Protein (2004) (0)
- Characterization of a small molecule IRAK4 kinase inhibitor for the treatment of autoimmune and inflammatory diseases (2016) (0)
- Delineation of Structural Constraints Imposed by a Dimerizer Peptide When Grafted Onto the Terminal Ends of a Test Peptide (2001) (0)
- A process for the treatment of cell proliferation disorders with pyrimidindiaminverbindungen (2007) (0)
- Integration de biodonnees multidimensionnelles et inference de relation (2002) (0)
- Quantitative Analysist (0)
- Abstract 3021: Development of small molecule direct AMPK activators for the treatment of cancer (2016) (0)
- Novel small molecule inhibitors of the Axl receptor tyrosine kinaseblock tumor growth (2007) (0)
- Optimization of Pyrimidine Compounds as Potent JAK1 Inhibitors and the Discovery of R507 as a Clinical Candidate. (2022) (0)
- Abstract 2546: AXL targeted therapy blocks tumor progression and prevents tumor metastasis in pancreatic cancer (2011) (0)
- Conditionally effective bispecific therapeutics (2018) (0)
- Structural implications of a novel peptide dimerizer sequence when anchored to terminal ends of different peptide motifs (2002) (0)
- Targeting autoimmunity: strategies and tactics. (2014) (0)
- Interaction of Analgesic Capsaicin Analogs with Substance P Receptors (1987) (0)
- Bicyclic pyrimidine compounds as potent IRAK4 inhibitors. (2022) (0)
- Friday morning – Abstracts 130-225 WRM 130 Survey of Analytical Techniques Useful for Thin Film Material Evaluation in High Technology Applications (2013) (0)
- 46 A Class of Small Molecules that Inhibit TNFα-induced Survival and Death Pathways via Prevention of Interactions between TNFαRI, TRADD and RIP1 (2007) (0)
- Multiparameter FACS test for the detection of alterations in cellular parameters (1999) (0)
- Global metabolite profiling of mice with high-fat diet-induced obesity chronically treated with AMPK activators R118 or metformin reveals tissue-selective alterations in metabolic pathways (2014) (0)
- Targeting Myeloproliferative Diseases with JAK2 Inhibitors. (2007) (0)
- R970, A Selective Activator of Nrf2, is Efficacious in a Murine Model of Multiple Sclerosis (2016) (0)
- Abstract 4869: Small molecule inhibitors of the anti-inflammatory TAM receptor MerTK (2016) (0)
- In vitro and in vivo characterization of small molecule inhibitors of the anti-inflammatory TAM receptor MerTK (2016) (0)
- Evaluation and Management of Infections in Patients with Collagen Vascular Disease (1988) (0)
- METHOD FOR THE TREATMENT OR PRuVENTION AUTOIMMUNE DISEASES WITH 2,4-pyrimidinediamine CONNECTIONS (2003) (0)
- Substance P stimulation of cultured human smooth muscle cells (1986) (0)
- Multiparameter facs test to determine from changes in cellular parameters (1999) (0)
- 2,4-pyrimidindiaminforbindelser and uses thereof (2003) (0)
- Identification and functional characterization of a novel human Misshapen/Nck interacting kinase-related kinase, hMINKβ. Vol. 279 (2004) 54387–54397 (2005) (0)
- Identification of Polo-like Kinase 1 inhibitors through phenotype-based approaches (2007) (0)
- Brain Abscess by Mycoplasma hominis (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Donald G. Payan?
Donald G. Payan is affiliated with the following schools: